NCT03865823

Brief Summary

Fistula is a pathology that can be complex and lead to treatment difficulties for the proctologist. The proctologist's objective is to treat the infection (anal fistula and abscess) with the minimum impact on anal continence. Drainage of the fistula pathway(s) and removal of infected tissue during initial surgery are essential. The treatment of upper trans-sphincterial fistulas, i. e. those that span more than half the height of the anal sphincter, poses risks to anal continence. It sometimes requires several times of surgical treatment. The study aim to investigate the fate of all patients treated for anal fistula in an expert team, in terms of impact on healing and anal continence and according to the type of anal fistula, the co-morbidity, the surgical techniques used and the bacterial flora responsible.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 4, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 7, 2019

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

7 years

First QC Date

March 4, 2019

Last Update Submit

September 17, 2025

Conditions

Keywords

anal fistulaanal infection

Outcome Measures

Primary Outcomes (1)

  • Healing rate at 2 years after initial surgical management of anal fistula.

    Healing is defined by the absence of anal pain, pus discharge and anal swelling reported by the patient.

    2 years

Secondary Outcomes (8)

  • Anal incontinence rate in participants operated for anal fistula, 2 years after initial care.

    Year 2

  • Healing rate in participants operated for anal fistula, at 6, 12 and 24 months after initial care.

    Month 6, 12, 24

  • Assessment of time to consolidated recovery.

    Month 24

  • Description of the number of surgeries required to obtain a cure.

    2 years

  • Bacteriological profile at the level of the fistula at the time of diagnosis and research into a possible role in the cure rate, the surgical technique used and the rate of post-operative incontinence.

    2 weeks

  • +3 more secondary outcomes

Study Arms (1)

anal Fistula

patient with anal fistula with indication to surgical treatment

Procedure: pus sample

Interventions

pus samplePROCEDURE

A pus sample from the fistula will be taken by the doctor during this first consultation or, failing that, in the operating room before disinfection.

anal Fistula

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with an anus fistula with indication for surgical treatment

You may qualify if:

  • Patient over the age of 18, patient with an anus fistula with indication for surgical treatment

You may not qualify if:

  • Cutaneous Suppuration, without fistula (e.g., Verneuil disease, boil)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Diaconesses Croix Saint Simon

Paris, 75020, France

Location

MeSH Terms

Conditions

Rectal Fistula

Condition Hierarchy (Ancestors)

Intestinal FistulaDigestive System FistulaDigestive System DiseasesIntestinal DiseasesGastrointestinal DiseasesRectal DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2019

First Posted

March 7, 2019

Study Start

March 1, 2019

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations